Loading...
XCNQ
ZRO
Market cap1mUSD
Jul 03, Last price  
0.05CAD
Name

Biosenta Inc

Chart & Performance

D1W1MN
XCNQ:ZRO chart
P/E
P/S
1,291.99
EPS
Div Yield, %
Shrs. gr., 5y
15.77%
Rev. gr., 5y
-4.57%
Revenues
1k
-12.18%
00000339,78058,367122,87880,48717,1781,16701,530168,1051,1511,0421,3791,211
Net income
-3m
L+12.49%
-77,042-331,972-504,791-845,648-2,324,004-2,282,911-4,449,316-3,528,1602,747,197-1,034,369-1,189,646-545,546-761,908-2,052,118-1,458,261-6,299,754-2,227,678-2,505,854
CFO
-455k
L-41.57%
-84,541-19,35099-765,639-1,087,437-1,290,330-1,832,596-1,218,471-589,110-217,456-225,064-326,731-319,729-672,287-504,433-550,788-779,348-455,376

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Biosenta Inc., a Toronto-based Canadian firm established in 1986, specializes in the development, manufacturing, and sale of antimicrobial chemical compounds for both residential and commercial applications throughout the country. The company is actively working on "true," an innovative, dual-action disinfectant with potent antimicrobial capabilities, engineered to instantaneously eradicate viruses, bacteria, mold, and various germs upon contact. Additionally, Biosenta Inc. intends to produce and distribute "Tri-Filler," an antimicrobial additive designed for bulking and filling purposes.
IPO date
Sep 22, 2005
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT